[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351293-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-351293-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","deciphering-multitarget-mechanisms-of-cardiac-glycosides-in-acute-myeloid-leukemia-using-a-network-pharmacology-and-molecular-docking","Deciphering Multitarget Mechanisms of Cardiac Glycosides in Acute Myeloid Leukemia Using a Network Pharmacology and Molecular Docking","","Acute myeloid leukemia (AML) remains highly aggressive, requiring novel therapies and faster drug development. The study investigates cardiac glycosides proscillaridin (PSN) and ouabain (OUA), focusing on shared multitarget mechanisms against leukemic stem cell (LSC) activity. An integrative in silico workflow integrates network pharmacology, bioinformatics, and molecular docking, with predictions supported by in vitro validation. Seventeen shared core targets and ten hub targets were identified, with docking and molecular dynamics supporting high-affinity binding, and in vitro assays showing suppression of downstream MTOR and PTGS2 signaling.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/deciphering-multitarget-mechanisms-of-cardiac-glycosides-in-acute-myeloid-leukemia-using-a-network-pharmacology-and-molecular-docking/351293/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/deciphering-multitarget-mechanisms-of-cardiac-glycosides-in-acute-myeloid-leukemia-using-a-network-pharmacology-and-molecular-docking/351293.png","ImageObject",300,407,{"name":42,"@type":43},"\tJames","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study on PSN and OUA in AML?","Question",{"text":63,"@type":64},"To clarify shared multitarget mechanisms by which proscillaridin (PSN) and ouabain (OUA) may exert anti-leukemic stem cell activity in acute myeloid leukemia.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which research approach was used to uncover molecular mechanisms?",{"text":68,"@type":64},"An integrative in silico framework combining network pharmacology, bioinformatics, and molecular docking was used, with subsequent in vitro validation to support the predictions.",{"name":70,"@type":61,"acceptedAnswer":71},"What hub targets were identified as functionally interconnected?",{"text":72,"@type":64},"Ten hub targets were reported: MTOR, PTGS2, ALB, ICAM1, SYK, PRKCA, MAPK14, MET, PRKCB, and MAP2K1.",{"name":74,"@type":61,"acceptedAnswer":75},"How did the study validate compound effects on signaling pathways?",{"text":76,"@type":64},"Molecular docking and dynamics supported high-affinity binding (notably to MTOR and PTGS2), and in vitro results showed that both PSN and OUA suppressed MTOR- and PTGS2-associated downstream signaling.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},351293,1790173547,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Drug Design, Development and Therapy  \nOpen Access Full Text Article ORIGINAL RESEARCH  \nDeciphering Multitarget Mechanisms of Cardiac Glycosides in Acute Myeloid Leukemia Using a Network Pharmacology and Molecular Docking  \nParinya Samart 1 , 2 , Jirarat Poohadsuan 1 , Supasorn Chanthateyanonth 1 , Surapol Issaragrisil 1 , 3 ,4 , Sudjit Luanpitpong 1 , 2  \n1Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 2Molecular Cancer Therapeutics Research Group, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 3Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 4BDMS Center of Excellence for Hematology, Wattanosoth Cancer Hospital, Bangkok, Thailand  \nCorrespondence: Sudjit Luanpitpong, Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Siriraj Hospital, Bangkoknoi, Bangkok, 10700, Thailand, Tel +662 419 2907, Email suidj[it@gmail.com](it@gmail.com)  \n\n| Purpose: Acute myeloid leukemia (AML) remains the most aggressive form of leukemia, underscoring the urgent need for novel treatment strategies. Drug repurposing offers a promising approach to accelerate drug development process. Cardiac glycosides (CGs), traditionally used for heart conditions, have shown potential for AML therapy. As leukemic stem cells (LSCs) are key contributors to AML relapse and chemotherapy resistance, this study aims to elucidate the potential shared mechanisms of proscillaridin (PSN) andouabain (OUA), two CGs with anti-LSC activity, focusing on their multitarget effects—an emerging strategy in cancer therapy. Methods: An integrative in silico framework combining network pharmacology, bioinformatics, and molecular docking was employed to elucidate the molecular mechanisms, identify clinically relevant targets, and evaluate the binding potential of PSN and OUA, with predictions were subsequently supported by in vitro validation.\u003Cbr>Results: Seventeen shared core targets of PSN–OUA in AML were identified by intersecting compound-predicted targets from SwissTargetPrediction with AML-relevant genes curated from clinical databases. Enrichment analyses using Gene Ontology, KEGG, and CancerGeneNet revealed strong associations of these core targets with key biological pathways involved in aggressive cancer phenotypes, including cell growth, apoptosis, and motility, which were subsequently validated to be affected by CGs in vitro. Protein– protein interaction mapping identified 10 hub targets—MTOR, PTGS2, ALB, ICAM1, SYK, PRKCA, MAPK14, MET, PRKCB, and MAP2K1—that are functionally interconnected and associated with clinical outcomes. Molecular docking and molecular dynamics simulations supported the high-affinity binding of PSN and OUA, particularly to MTOR and PTGS2 . Consistently, both compounds suppressed MTOR-and PTGS2-associated downstream signaling in vitro.\u003Cbr>Conclusion: Our findings elucidate multiple mechanisms by which CGs may exert anti-LSC activity, which could be crucial for the design of novel therapeutic strategies for AML. The proposed in silico framework is broadly applicable and may accelerate drug repurposing in AML and other cancers.\u003Cbr>Keywords: acute myeloid leukemia, proscillaridin, ouabain, network pharmacology, enrichment analysis, molecular docking |\n| --- |\n| Introduction\u003Cbr>Acute myeloid leukemia (AML) is considered the most clinically aggressive form of leukemia, accounting for nearly half of leukemia-related deaths, with a median age at diagnosis of approximately 69 years.1,2 Statistically, AML caused 0.145 million new cases and 0.130 million deaths worldwide in 2021, with incidence and mortality demonstrating a sustained upward trend over time, reflecting its high fatality.3,4 AML is driven by an uncontrolled proliferation of immature myeloid blasts, leading to their accumulation in peripheral blood","cbCaiki0Po5szkuH","https://ap.wps.com/l/cbCaiki0Po5szkuH","pdf",13436122,26,"English","# Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main goal of the study on PSN and OUA in AML?\",\"answer\":\"To clarify shared multitarget mechanisms by which proscillaridin (PSN) and ouabain (OUA) may exert anti-leukemic stem cell activity in acute myeloid leukemia.\"},{\"question\":\"Which research approach was used to uncover molecular mechanisms?\",\"answer\":\"An integrative in silico framework combining network pharmacology, bioinformatics, and molecular docking was used, with subsequent in vitro validation to support the predictions.\"},{\"question\":\"What hub targets were identified as functionally interconnected?\",\"answer\":\"Ten hub targets were reported: MTOR, PTGS2, ALB, ICAM1, SYK, PRKCA, MAPK14, MET, PRKCB, and MAP2K1.\"},{\"question\":\"How did the study validate compound effects on signaling pathways?\",\"answer\":\"Molecular docking and dynamics supported high-affinity binding (notably to MTOR and PTGS2), and in vitro results showed that both PSN and OUA suppressed MTOR- and PTGS2-associated downstream signaling.\"}]","Deciphering Multitarget Mechanisms of Cardiac Glycosides in Acute Myeloid Leukemia Using a Network Pharmacology and Molecular Docking | PDF",1790093420,66,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49830fc60b77335391a3662832ccbdc4.webp",983,1272,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21e1660103546d4bd5326f3238952093.webp",982,1270,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ccd98b102c130081ae188b7715bd5e5.webp",981,1269,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6556b0181b851ff199f38edd92bbc245.webp",980,1268]